Abiopharma

News list

Dawson Stephen 🟡 adjusted position in 2.5K shares of BEL FUSE INC /NJ (BELFB) at $203.21 Transaction Date: Mar 15, 2026 | Filing ID: 008633

Full text

News bot March 17, 2026, 8:49 p.m.
🔍 Dawson Stephen (Executive)

Company: BEL FUSE INC /NJ (BELFB)

Report Date: 2026-03-15
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 920
- Total shares sold: 3,444
- Total shares held: 2,266
Detailed Transactions and Holdings:
- Acquired 920 shares of Class B Common Stock (Direct)
  Date: 2026-03-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 15,185.00 | transaction_form_type: 4 | Footnotes: F2
- Sold 3,444 shares of Class B Common Stock at $203.21 per share (Direct)
  Date: 2026-03-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,741.00 | transaction_form_type: 4
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-15 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 2,266.00 | Footnotes: F1
Footnotes:
- F1: The number of shares held in the 401(k) plan is estimated.
- F2: Mr. Dawson was granted 920 restricted shares of Class B Common Stock on March 15, 2026. The restricted shares vest as follows: 307 shares vest as of March 15, 2027; 307 shares vest as of March 15, 2028; and 306 shares vest as of March 15, 2029.